Strategic KOL Management: Performance Measurement, Staffing and Success Factors

STUDY OVERVIEW

While the evolving U.S. healthcare system is altering many aspects of the biopharmaceutical marketplace, the importance of Key Opinion Leaders (KOLs) remains unchanged. The influence of KOLs continues to extend from clinical programs and medical education to prescribing habits and payer access. Consequently, it's vital for biopharmaceutical organizations to effectively manage these important and often complex relationships through systems, processes, and procedures.

Best Practices, LLC conducted this research to help organizations create and maintain a strategic KOL management system. In particular, this study examines current approaches to performance measurement, staffing and success factors for a strategic KOL management system. This study provides an evidence-based understanding of current and evolving approaches to creating and maintaining an integrated, strategically-focused KOL management system.

KEY TOPICS

• Measuring Strategic Thought Leader Management and Engagement Success
• Staffing Strategic Thought Leader Management and Engagement
• Looking Forward: Success Factors for Strategic TL Management & Engagement
  

• How is strategic KOL management assessed within your company
• How do you get feedback from KOLs regarding company interactions
• What are the top three things KOLs value most from interactions
• How much does your organization value day to day strategic KOL management
• Number of non-field based FTEs involved in your strategic KOL management
• Is there a clear career pathway for staff doing strategic KOL management
  

• Participants clearly feel that their organization sees some value in the day-to-day strategic KOL management – almost half think their company highly values the work while the remainder of respondents think their company somewhat values the work.
  

Thirty-four TL management leaders from 29 biopharma and device organizations participated in the external field survey, and we interviewed 4 participants for in-depth insights

Industries Profiled:
Health Care; Pharmaceutical; Biotech; Medical Device; Manufacturing; Education; Science; Biopharmaceutical; Clinical Research; Laboratories; Medical


Companies Profiled:
Abbott Nutrition; Abbvie; Amgen; Antibiotice; Astellas; Baxter Healthcare; Biogen Idec; Boehringer Ingelheim; Crescendo Bioscience; Cubist Pharmaceuticals; Eisai; Intermune; Janssen; Jazz Pharmaceuticals; Mallinckrodt; Marcyrl; Medtronic; Merck; MSD; Onyx Pharmaceuticals; Pierre Fabre Medicament; ProStrakan; Reliance Institute of Life Sciences; Roche; Sanofi; Sanofi Renal; Servier; Shire; TauRx Therapeutics; Janssen Biotech; Inc.; A.P. Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.